Preliminary results from a phase 1 trial of M7824 (MSB0011359C), a bifunctional fusion protein targeting PD-L1 and TGF-β, in advanced solid tumors. This is an ASCO Meeting Abstract from the 2017 ASCO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results